Muscle Loss With Age: Causes and Prevention

Muscle loss with age, known clinically as sarcopenia, is a gradual but significant process that affects nearly everyone from their thirties onwards. Driven by hormonal shifts, reduced physical activity and changes in how the body processes protein, it can quietly erode strength, balance and independence long before symptoms become obvious. Understanding why muscle loss happens, when it becomes a genuine health concern, and what practical steps can slow it down is essential for maintaining quality of life as we get older. This article covers the key causes, health consequences and evidence-based strategies for managing muscle loss across older age.

Why do we lose muscle as we get older?

Muscle loss with age occurs because declining anabolic hormones, reduced motor neuron sensitivity, chronic low-grade inflammation and mitochondrial dysfunction all tip the balance between muscle protein synthesis and breakdown unfavourably.

Muscle loss with age, known clinically as sarcopenia, occurs because the body gradually becomes less efficient at building and maintaining muscle tissue, a process driven by hormonal, neurological and cellular changes. From around the fourth decade of life, the balance between muscle protein synthesis and muscle protein breakdown begins to tip unfavourably, meaning the body breaks down muscle faster than it can rebuild it.

Several biological mechanisms contribute to this shift. Levels of anabolic hormones, including testosterone, oestrogen and growth hormone, decline with age, reducing the stimulus for muscle protein synthesis. At the same time, the number and sensitivity of motor neurons that activate muscle fibres decrease, leading to a gradual loss of fast-twitch muscle fibres in particular. These fibres are responsible for strength and explosive movement, which is why older adults often notice a reduction in power before they notice a reduction in overall muscle bulk.

Inflammation also plays a role. Chronic low-grade inflammation, sometimes described as inflammageing in the scientific literature, is associated with increased levels of cytokines that promote muscle protein breakdown. Mitochondrial dysfunction within muscle cells further impairs energy production and repair capacity. These mechanisms are described in the 2019 consensus update from the European Working Group on Sarcopenia in Older People (EWGSOP2), published in Age and Ageing, which remains the principal reference framework for sarcopenia in clinical practice.^[1] Physical inactivity accelerates all of these processes considerably, creating a cycle in which reduced activity leads to further muscle loss, which in turn makes activity harder to sustain.

At what age does muscle loss become a real health concern?

Muscle loss becomes measurable from around age 30 to 40, but becomes a significant clinical concern after 60, when cumulative losses can impair function and raise the risk of falls, fractures and premature mortality.

Muscle loss becomes a measurable health concern from around the age of 30 to 40, when adults can begin to lose roughly 3 to 8 per cent of muscle mass per decade, with the rate accelerating significantly after the age of 60. By the time a person reaches their seventies or eighties, cumulative losses can be substantial enough to impair everyday function and increase the risk of serious health outcomes.

Sarcopenia is not simply a cosmetic issue. Clinically significant muscle loss is associated with an increased risk of falls, fractures, hospitalisation and premature mortality. The EWGSOP2 defines sarcopenia as a progressive skeletal muscle disorder involving low muscle strength, low muscle quantity or quality, and poor physical performance. Diagnostic thresholds include grip strength and gait speed or Short Physical Performance Battery (SPPB) scores; clinicians and healthcare professionals can refer to the full EWGSOP2 2019 consensus (Cruz-Jentoft et al., Age and Ageing, 2019) for specific cut-off values. Using this framework, sarcopenia affects an estimated 10 per cent of adults over 60 and a considerably higher proportion of those over 80, though prevalence figures vary depending on the diagnostic criteria applied.^[13]

It is worth noting that muscle loss does not affect everyone equally. Genetics, habitual physical activity, nutritional status, chronic illness and medication use all influence the rate and severity of decline. People who are physically inactive, have poor nutritional intake, or live with conditions such as type 2 diabetes, chronic obstructive pulmonary disease or heart failure tend to experience more rapid and pronounced muscle loss. Recognising the concern early, ideally before significant functional decline has occurred, offers the best opportunity for effective intervention.

How does sarcopenia affect your daily life and independence?

Sarcopenia reduces the strength and balance needed for everyday tasks, increases fall risk and is linked to insulin resistance, social withdrawal and reduced quality of life in older adults.

Sarcopenia affects daily life by reducing the strength, balance and endurance needed to carry out routine tasks, from climbing stairs and carrying shopping to rising from a chair without assistance. As muscle mass and strength decline, even activities that once felt effortless can become effortful or unsafe.

One of the most significant consequences is an increased risk of falls. Muscle weakness, particularly in the lower limbs, impairs balance and the ability to react quickly to a stumble. Falls are a leading cause of injury-related hospital admissions among older adults in the UK. According to NICE guidance on falls in older people, around one in three adults over 65 falls at least once a year. Fractures resulting from falls, especially hip fractures, carry a high risk of long-term disability and loss of independence.

Beyond falls, sarcopenia is associated with a broader decline in physical performance that can affect confidence and mental wellbeing. Older adults who struggle with physical tasks may reduce their activity levels further, withdraw from social activities and become more reliant on others for daily care. This can contribute to social isolation, low mood and a reduced quality of life.

Sarcopenia also has metabolic consequences. Muscle tissue is metabolically active and plays an important role in glucose regulation. Loss of muscle mass is associated with insulin resistance and an increased risk of developing type 2 diabetes.^[1][13] Maintaining muscle mass is therefore relevant not only to physical function but to broader metabolic health across older age.

What can you do to slow down muscle loss as you age?

Resistance exercise targeting all major muscle groups on at least two days per week is the most effective strategy, supported by staying generally active, adequate sleep, and avoiding smoking and excess alcohol.

Resistance exercise is the most effective evidence-based strategy for slowing muscle loss with age, and it remains beneficial even when started in later life. Activities that challenge muscles against a load, such as weight training, resistance band exercises, bodyweight movements and certain forms of yoga or Pilates, stimulate muscle protein synthesis and help preserve both muscle mass and strength.

Current UK physical activity guidelines, as set out in the UK Chief Medical Officers' Physical Activity Guidelines (2019) and reflected in NHS guidance, recommend that adults aged 65 and over engage in:

• Strengthening activities on at least two days per week, targeting all major muscle groups

• At least 150 minutes of moderate-intensity aerobic activity per week, or 75 minutes of vigorous-intensity activity

• Balance and coordination exercises on at least two days per week to reduce fall risk (also recommended in NICE guidance on falls in older people)

For those new to resistance exercise or managing existing health conditions, starting gradually and seeking guidance from a physiotherapist or qualified exercise professional is advisable. Many NHS services and community programmes offer supervised exercise for older adults, and GP referral to a structured exercise programme may be available in some areas, though provision varies locally.

Beyond formal exercise, staying generally active throughout the day matters. Reducing prolonged sitting, walking regularly and incorporating movement into daily routines all contribute to preserving muscle function. Smoking cessation and limiting alcohol intake are also relevant, as both are associated with accelerated muscle loss and impaired recovery.^[14][15] Adequate sleep supports muscle repair and hormonal balance, making it another modifiable factor worth addressing.

Does diet make a difference to muscle loss in older adults?

Diet significantly affects muscle loss; older adults benefit from a protein intake of 1.2 to 1.6 g per kg of body weight daily, alongside a daily 10-microgram vitamin D supplement and adequate hydration.

Diet makes a meaningful difference to the rate of muscle loss in older adults, with protein intake being the most important dietary factor for preserving muscle mass and supporting its repair after exercise. Older adults require more dietary protein than younger adults to achieve the same anabolic response, partly because of a phenomenon known as anabolic resistance, in which ageing muscle becomes less sensitive to the muscle-building stimulus of amino acids.^[7][8]

Current evidence, including guidance from the British Dietetic Association (BDA), suggests that older adults aiming to preserve muscle mass may benefit from a protein intake of around 1.2 to 1.6 grams per kilogram of body weight per day, spread across meals rather than concentrated in one sitting. However, protein requirements vary depending on health status, and this range may not be appropriate for everyone. In particular, people with chronic kidney disease or those who have been advised to follow a protein-restricted diet should seek personalised advice from a dietitian or GP before increasing their protein intake. Good dietary sources of protein include:

• Animal sources: lean meat, poultry, fish, eggs and dairy products

• Plant sources: legumes, tofu, tempeh, edamame, nuts and seeds

• Fortified foods and protein-enriched products, which may be useful for those with reduced appetite

Vitamin D is also relevant to muscle health. Low vitamin D levels are associated with muscle weakness and an increased risk of falls.^[10][11] Current UK government advice, as set out on the NHS website and informed by the Scientific Advisory Committee on Nutrition (SACN) Vitamin D and Health report, recommends that adults in the UK consider a daily supplement of 10 micrograms (400 IU) of vitamin D throughout the year, particularly during autumn and winter months when sunlight exposure is limited. Some at-risk groups, including older adults who are housebound or have limited sun exposure, may benefit from year-round supplementation.

Calcium supports bone health alongside muscle function, and adequate hydration is often overlooked but important for muscle performance. Older adults with poor appetite, difficulty chewing or swallowing, or significant unintentional weight loss should be assessed by a dietitian, as these factors can accelerate nutritional deficits and muscle decline.

When should you speak to a GP about muscle weakness or loss?

See a GP if you notice rapid strength decline, frequent falls, unexplained weight loss or difficulty with daily tasks; seek emergency care for sudden one-sided weakness, as this may indicate a stroke.

You should speak to a GP about muscle weakness or loss if you notice a significant or rapid decline in your strength, difficulty performing everyday tasks that were previously manageable, unexplained weight loss, or frequent falls. These symptoms may indicate sarcopenia or an underlying condition that warrants investigation.

A GP can assess muscle strength and physical performance using validated tools, such as grip strength measurement or the Short Physical Performance Battery, and can arrange relevant investigations. These may include blood tests to check for nutritional deficiencies (including vitamin D, B12 and iron), thyroid function, inflammatory markers and blood glucose, as well as assessment for conditions such as anaemia, chronic kidney disease or neurological disorders that can contribute to muscle weakness. Where drug-induced or inflammatory myopathy is suspected, for example in someone who has recently started a statin or corticosteroid, a creatine kinase (CK) measurement may also be appropriate.

Referral pathways following a GP assessment may include:

• Physiotherapy, for a structured exercise programme tailored to your current ability

• Dietetic assessment, if nutritional deficiency or poor intake is suspected

• Falls prevention services, if balance or fall risk is a concern

• Specialist geriatric or rheumatology review, if an underlying condition is identified

Call 999 immediately if you or someone else develops sudden weakness or numbness on one side of the body, facial drooping, difficulty speaking or understanding speech, or sudden severe headache, as these may be signs of a stroke requiring emergency treatment. Seek urgent medical attention if you develop severe muscle pain or weakness alongside dark or discoloured urine, as this may indicate rhabdomyolysis, a serious condition requiring prompt assessment.

If you experience sudden, severe or rapidly worsening muscle weakness accompanied by difficulty breathing, swallowing or speaking, contact NHS 111 for urgent advice or attend A&E if symptoms are severe and developing quickly.

Healthcare professionals and patients can report suspected adverse effects of any medicine that may be contributing to muscle weakness using the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk. Certain medicines, including statins and corticosteroids, are known to affect muscle function and should be reviewed by a GP if muscle symptoms develop after starting or changing a medication.

Scientific References

1. Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2). Cruz-Jentoft AJ et al. Age Ageing..
2. Skeletal muscle as potential central link between sarcopenia and immune senescence. Nelke C et al..
3. Falls: assessment and prevention in older people (NG249). NICE..
4. Falls: applying All Our Health. GOV.UK / UKHSA..
5. UK Chief Medical Officers' Physical Activity Guidelines..
6. Physical activity guidelines for adults aged 19 to 64. NHS..
7. Anabolic resistance of muscle protein synthesis with aging. Burd NA et al. Exercise and Sport Sciences Reviews..
8. Age-related muscle anabolic resistance: inevitable or preventable? Aragon AA et al. Nutrients..
9. Addressing sarcopenia. British Dietetic Association..
10. Vitamin D deficiency, muscle function, and falls in elderly people. Janssen HCJP et al. American Journal of Clinical Nutrition..
11. SACN Vitamin D and Health report. Scientific Advisory Committee on Nutrition..
12. Vitamin D. NHS..
13. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Yuan S et al. Metabolism..
14. Association between cumulative pack-year smoking exposure and sarcopenia: a KoGES cohort study. International Journal of Epidemiology..
15. Smoking and Diabetes as Predictive Factors of Accelerated Loss of Muscle Mass in Middle-Aged and Older Women. Journal of Women's Health..

Frequently Asked Questions